MAINTENANCE SOP Calibration Policy Pfizer

You might also like

Download as pdf or txt
Download as pdf or txt
You are on page 1of 35

Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility

IPPC Licence Application

ATTACHMENT F.1 A Draft Standard Operating Procedure for Calibration


B Pfizer Ireland Pharmaceuticals Maintenance Strategy

.
se
ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC Page 1 24 September 2008
ATTACHMENT F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

MAINTENANCE SOP
PFIZER SMALL SCALE MONOCLONAL ANTIBODY FACILITY
SHANBALLY IRELAND

CALIBRATION POLICY

Document No:
Draft

.
se
This procedure is intended as an overview of the approach to equipment and instrument calibration at the
ru
he
Shanbally MABS Small Scale Facility.
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu

Approval Role / Department Name Signature Date


ow ion
ht ct
ig pe
yr ns
op r i

Author Engineering Vincent Coleman


f c Fo

Reviewed By Engineering Declan J Murphy


to
en

Approved By Engineering Liam O’Brien


ns
Co

Revision History

Document
Revision Date Name Reason for Update
1 29/07/08 Vincent Coleman Original

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC Page 2 24 September 2008
ATTACHMENT F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

TABLE OF CONTENTS

1.0 PURPOSE 4

2.0 SCOPE 4

3.0 APPLICABLE PERSONNEL 4

4.0 DEFINITIONS ACRONYMS AND SYMBOLS 5

5.0 RULES AND GUIDELINES 8


5.1 Calibrations 8
5.2 Instrument Specifications 8
5.3 Records 9
5.4 Selection and Use of Calibration Standards 11
5.5 Calibration Instruction and Instruction Numbers 11

.
se
5.6 PM Schedule Codes 12 ru
he
ot

5.7 Calibration Labels 12


ny
fo y.
d nl
ra

5.8 Instrument Tolerances 12


re o
ui es

5.9 Calibration Certificates 12


eq os
r r rp

5.10 Calibration Intervals 13


ne pu
ow ion
ht ct
ig pe

6.0 SAFETY PRECAUTIONS 14


yr ns
op r i
f c Fo

7.0 CREATING/MODIFYING INSRUMENT/PM/CALIBRATION INSTRUCTION RECORD


14
to
en
ns
Co

8.0 DEACTIVATING EQUIPMENT 15

9.0 ACTIVATING EQUIPMENT 16

10.0 REQUEST PM EXTENSION 16

11.0 PERFORMING CALIBRATIONS 17

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 3 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

1.0 PURPOSE
To provide an overview of the approach to instrument calibration at the Shanbally Small Scale
Facility (SSF), which establishes the requirements for calibration of equipment, instruments, and
standards used in production, storage, and testing that may affect the identity, strength, quality,
or purity of product.

2.0 SCOPE
This calibration procedure applies to the SSF, defining the responsibilities, criteria, and
documentation requirements for the calibration of equipment and instruments used on site.
Calibration of all production and facility equipment is included in the scope of the SOP.
Calibration of Laboratory equipment is excluded.

3.0 APPLICABLE PERSONNEL


This procedure applies to all Pfizer colleagues and to contractors who request, perform or

.
se
approve calibration activities. ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 4 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

4.0 DEFINITIONS ACRONYMS AND SYMBOLS


Calibration
Set of operations that establish, under specified conditions, the relationship between values of
quantities indicated by a measuring instrument or measuring system or values represented by a
material measure or a reference material, and the corresponding values realised by standards.

Calibration Interval
The interval, in days, between successive calibrations.

Calibration Instruction Number


The unique number assigned by the Calibration Co-Coordinator to a new calibration
task.

Calibration Standard
This is the designated measuring equipment used routinely to calibrate or check
measuring instruments, or material measures. This is also referred to as Working
Standard, Transfer Standard or Reference Standard.

.
se
Calibration Range ru
he
Specified range over which the instrument is calibrated. This should at least cover the
ot
ny
fo y.

normal operating range.


d nl
ra
re o
ui es
eq os
r r rp

cGMP
ne pu
ow ion

Current Good Manufacturing Practices.


ht ct
ig pe
yr ns
op r i

CMMS
f c Fo

Computerised Maintenance Management System. The integrated modular computerised


to

system used at the SSF to control all maintenance and calibration activities.
en
ns
Co

Calibration Co-ordinator
Responsible for the overall management of the plant calibration programme.

CMMS Administrator
Responsible for the CMMS administration of all maintenance related activities within the
plant.

Calibration Instructions
A set of instructions which describes the process for calibrating an instrument.

Device Input & Output Range


Range over which instrument is capable of measuring. Provided in manufacturer’s
specification.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 5 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Environmental Critical Instruments


An instrument that is used to assure environmental compliance and which have
appreciated environmental implications if it fails on demand.

GMP Critical Instruments


Instruments used directly to manufacture, process, package and/or hold pharmaceutical
products or drug substances and as a result whose failure may directly affect product
quality.

Increment
Smallest difference between indications of a displaying device that can be meaningfully
distinguished.

Instrument/Standard ID Label
The label containing the Instrument/Standard ID Number.

Instrument/Standard ID Number
The unique number assigned by the Calibration Co-ordinator to each loop or individual
instrument/standard that is not part of a loop.

.
se
Loop Calibration ru
he
ot

Calibration of a group of instruments connected together to monitor, or control a process


ny
fo y.
d nl
ra

variable.
re o
ui es
eq os
r r rp
ne pu

Non Critical Instruments


ow ion

Instruments whose function is important to the operation or efficiency of parent


ht ct
ig pe

equipment but whose failure are deemed to have no effect on product quality
yr ns
op r i
f c Fo

Normal Operating Range (NOR)


to

Specified range within which the process NORMALLY operates.


en
ns
Co

Process Control Limit


The maximum allowable error in the measured reading within the process.

QAR Notification Form


A report generated to notify relevant personnel when GMP critical equipment is found
operating outside of design parameters.

Standard Calibration Label


The label containing the calibration information for a calibration standard.

Safety Critical Instruments


An instrument which is used to assure the safety of personnel and equipment and which
has appreciable safety implications if it fails on demand.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 6 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Traceability
Property of the result of a measurement or the value of a standard whereby it can be
related to stated references, usually national or international standards, through an
unbroken chain of comparisons all having stated uncertainties.

Unit Of Measure (UOM)


Unit Of Measure

.
se
ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 7 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

5.0 RULES AND GUIDELINES


5.1 Calibrations

1. The Engineering Department is responsible for the administration of the Calibration System
and that the Calibration program is reviewed on an annual basis. A work order is generated in
the CMMS and the Engineering Department reviews the Calibration System.
2. All calibrations will be scheduled through the CMMS.
3. Calibrations will be loop calibrations where possible.
4. One record will be generated in the CMMS for each instrument or loop.
5. Where applicable the CMMS record will reference the P&ID tag number of the instrument or
loop and the instrument ID number as assigned by the calibration co-ordinator.
6. The instrument ID number will be assigned to the instrument or loop when the CMMS record
is generated.
7. Calibration shall be conducted at a minimum of three points (e.g. upper optional range, lower
optional range and NOR), if possible. For instruments that cannot be calibrated at three
points, the points to be included in the calibration shall be defined and justified.
8. Calibrations will be scheduled and performed in accordance with best calibration and cGMP
practices and applicable safety and environmental policies
9. Instruments will be calibrated over their device Input & Output range, where practical.
10. Where it is not practical to calibrate the instrument over the full range, the instrument must at

.
se
a minimum; be calibrated over the normal operating range. ru
he
11. Measurement instruments will be re-calibrated if dropped jarred or damaged.
ot
ny
fo y.

12. Loop components must be individually calibrated prior to installation in the loop or in the
d nl
ra
re o
ui es

event of overall loop failure during routine calibration of the loop.


eq os
r r rp
ne pu
ow ion
ht ct
ig pe

5.2 Instrument Specifications


yr ns
op r i
f c Fo

13. Instrument specifications shall be established prior to defining the calibration method for the
instrument and shall be based on the requirements of the application and specific
to

parameter(s) that the instrument is intended to measure.


en
ns

14. Instrument Specification shall include, and are not limited to:
Co

• Definition of required tolerance and precision


• Expected process parameter values, including unit of measure
• Expected NOR of the process parameter values.
• Acceptable Tolerance
• Instrument stability requirements
• Safety and environmental consideration.

The instrument specification record shall be attached to the “Instrument Change


Record Form”. Prior to removing an instrument from service, a final calibration shall
be performed, if possible (i.e. instrument still functional), to verify that the
instrument is still within tolerance.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 8 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

• Initial “As found” data shall be recorded prior to removing an instrument


from the calibration schedule, performing and upgrade, or before an
instrument is moved. If the instrument is not calibrated prior to a move, the
justification must be documented and approved by the site Quality Authority.
15. Personnel requesting Corrective Maintenance for GMP instruments are responsible for
completing a QAR form and for releasing a CM work order, as applicable
16. Calibrations shall not be performed unless environmental conditions are suitable for both the
measurement equipment and the calibration standard used.
17. Where a PM is to be extended for greater than 30% of the PM frequency (either single or
cumulative extensions), QA approval must be obtained by opening a planned QAR.
18. Criticality determination for instruments is as per the following: GMP, Safety,
Environmental, GMP and Safety, GMP and Environmental and non-critical are CLS01,
CLS02, CLS03, CLS04, AND CLS09 respectively
19. Instruments will be considered overdue for calibration after the due date if the calibration has
not been completed. A calibration due-date extension may be granted provided that
reasonable assurances can be made based on the instrument calibration history and/or a
statement from the original equipment manufacturer that continued equipment use for a
limited time would not affect performance.
20. A QAR Notification (QAR) form must be completed if a GMP critical instrument is not

.
se
calibrated by the due date and the associated equipment is used to manufacturer product.
ru
he
21. If a GMP critical instrument is found to be out of tolerance, a QAR must be initiated and
ot
ny
fo y.

must include a product quality impact assessment carried out in conjunction with the
d nl
ra
re o

process/manufacturing owner and the person performing the calibration.


ui es
eq os

22. A full instrument criticality assessment must be made for all new instruments.
r r rp
ne pu

23. New equipment will be tagged “Do Not Use” until the criticality status and calibration
ow ion
ht ct

requirements of instruments associated with it are evaluated.


ig pe
yr ns

24. Instruments already classified as Non Critical are calibrated at the sole discretion of
op r i
f c Fo

engineering.
25. Stationary instruments must be re-calibrated after movement.
to

26. Any instrument that has been repaired must be re-calibrated before being returned to service.
en
ns

27. Trained personnel only will carry out calibrations and are detailed on file with HR (Human
Co

Resources) and the Calibration Co-Ordinator.


28. Learning records will be maintained for all personnel engaged in performing and
administering the calibration program.
29. Calibrations performed by vendors or contract services must meet the requirements of this
document.
30. Vendors to be reviewed and audited as deemed necessary by the site quality authority.
31. Vendors/contractors must have procedures that assure the accuracy and traceability of their
reference and test equipment.
32. All efforts should be made to keep instruments as accurate as possible. Thus instruments
should be adjusted even if within tolerance but approaching the limits.
33. Individual calibration tasks must be maintained for each instrument calibrated. These tasks
can be a guideline described in the manufacturer’s manual or written procedures that may be
contained in CMMS.

5.3 Records
34. An instrument record must be maintained for each loop or instrument. The instrument record
must provide sufficient information to set up a replacement loop and/or instrument, if
necessary.
35. For original loop records, hard copies of the element/transmitter certificates will be attached
and filed with the original loop calibration certificate in the QA DCC (document control

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 9 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

centre). All subsequent loop calibration certificates will be filed with these. This file will be
the record for loops and the loop components.
36. The calibration files will be organised by Instrument ID number.
37. A calibration certificate will be completed for each calibration carried out and then filed in
the calibration files.
38. Calibration intervals will be specified in days.
39. The next due date for calibration will be calculated from the date done.
40. All calibration activities must be recorded in the relevant Equipment Logbook.
41. The instrument or loop record must include the following
Instrument ID number
Instrument or loop description
System number that the instrument or loop is part of (as applicable)
Criticality
P & ID tag number of the instrument or loop
Date last calibrated ( as applicable)
Type
Manufacturer
Model number
Serial number
Location
Device Input/Output range
Calibration Failure Limit Device

.
se
or loop calibration interval ru
he
ot

Calibration Instruction reference


ny
fo y.
d nl
ra

Operating range ( where applicable)


re o
ui es

Process Control Limit (where applicable)


eq os
r r rp
ne pu
ow ion

Nominal Test points


ht ct
ig pe
yr ns
op r i
f c Fo

Note: Prefixes relating to nominal test points for weigh scales include:
to
en
ns

CTR: Centre (Point)


Co

FRT: Front Right (Load cell)

FLT: Front Left (Load cell)

BRT: Back Right (Load cell)

BLT: Back Left (Load cell)

RPT: Repeatability (Test)


The point of reference for the load cell locations being the local indicator.

42. For in-house standards, a calibration certificate shall be prepared based on supporting
raw data. The certificate shall include, and not be limited to:

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 10 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

• Description of standard
• Date the standard was established
• Signature of the person preparing the standard
• Date standard must be recertified or replaced
• Handling or storage conditions for the standard
• Reference to a method or task used to establish the standard
• Accuracy and precision of the standard.

5.4 Selection and Use of Calibration Standards


43. Standards used for calibrating measurement equipment will have the capability for accuracy,
stability and range needed for their intended use.
44. The calibration standard must always be more accurate than the instrument under test. Where
possible the uncertainty ratio should be 1:4. Where this is not practical, a less accurate
standard may be used with the approval of site QA.
45. Calibration certificates will support all calibration standards used in the calibration system.
Certificates for Pfizer standards will be filed in Pfizer document control. Certificates for
contractor standards must be available on request.

.
se
ru
46. A calibration standard, when not in use, shall be stored in a secure manner which prevents
he
ot

unauthorised adjustment.
ny
fo y.
d nl
ra

47. Standards must be safe to operate in the specific process area in which the equipment is
re o
ui es

being used. Ensure the standards are clean prior to use to prevent ‘Cross Contamination’.
eq os
r r rp

48. The storage environment shall meet the standard’s storage requirement.
ne pu
ow ion

49. Calibration Standards used in calibrating measurement equipment will be: Traceable to one
ht ct
ig pe

or more of the following; the National Institute of Standards and Technology (NIST), the
yr ns
op r i

National Physical Laboratory U.K. (NPL), the United Kingdom Accreditation Service
f c Fo

(UKAS), the National Standards Authority of Ireland (NSAI) or equivalent institutes.


50. Where applicable all calibration standards must be added to a Portable Appliance Testing
to
en

(PAT) schedule.
ns
Co

5.5 Calibration Instruction and Instruction Numbers


51. An instruction for the calibration of each type of Instrument (e.g. pressure gauge,
temperature transmitter, flow meter) shall be reviewed and approved by the system
expert/designee to ensure that the instructions are technically correct and are approved by the
site Quality Authority, Environmental Health and Safety principles shall be consulted if
required.

The format for Calibration Instruction numbers is:

CI-sequential number-revision number

For example, the first revision of the fiftieth calibration instruction would be
numbered: CI-0050-01.
Instructions will be filed in equipment files or calibration task files under calibration
instruction number.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 11 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

5.6 PM Schedule Codes


52. A PM schedule code will have the same code as the instruction code to which it is linked to
in CMMS.

5.7 Calibration Labels


53. Calibrate before use: the calibration label used for all calibrated loops or instruments that
must be calibrated before use. It contains the calibration date, signature of the person
performing the calibration, and the required calibration interval.
54. Do not use: the label attached to a loop or instrument that has not been calibrated, is over-due
for calibration, is not operating correctly, or must not be used for other reasons.
55. Instrument ID Labels: for loops, the Instrument ID label will be attached as close as
practicable to the measuring element of the loop.

56. An instruction for the calibration of each type of Instrument (e.g. pressure gauge,
temperature transmitter, flow meter) shall be reviewed and approved by the system
expert/designee to ensure that the instructions are technically correct and are approved by the
site Quality Authority, Environmental Health and Safety principles shall be consulted if
required.

5.8 Instrument Tolerances


57. Loop and instrument calibration tolerances will be based on manufacturers'

.
se
recommendations, process requirements, and stability of the instrument, purpose and
ru
accuracy and/or historical calibration data for similar instruments.
he
ot

58. Loop tolerances will be based on the cumulative effect of the individual component
ny
fo y.
d nl
ra
re o

accuracies, taking into account the resolution of the display.


ui es
eq os
r r rp
ne pu

For example:
ow ion
ht ct

Sensor ± 0.25°C,
ig pe
yr ns

Transmitter ± 0.05°C,
op r i
f c Fo

Input card ± 0.1°C,


to

Display reads out in 0.5°C increments,


en

Loop tolerance should be ± 1°C.


ns
Co

5.9 Calibration Certificates


59. A calibration certificate must be completed for each calibration carried out.
60. The calibration record must include the following:
• Instrument ID number
• Instrument or loop description
• Manufacturer
• Model
• Serial Number
• Location
• Device Input/Output Range
• Calibration Failure Limit
• Nominal test points

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 12 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

• Calibration interval
• Calibration Instruction reference
• Reference standards used for calibration, identification number and
calibration due date.
• ‘As found’ calibration data
• ‘As left’ calibration data, if applicable
• Reference to QAR Form, if applicable
• Instrument criticality
• Signature of person performing the calibration
• Date of calibration
• Signature of person approving the calibration
• Date of approval
• Comments

.
se
ru
he
ot

5.10 Calibration Intervals


ny
fo y.
d nl
ra

61. Calibration intervals will be specified in days.


re o
ui es
eq os

62. The next due date will be calculated, in days, from the date done.
r r rp
ne pu

63. Calibration intervals will be based on manufacturers' recommendations, stability of the


ow ion

instrument, and consequence of calibration failure, purpose and accuracy and/or historical
ht ct
ig pe

calibration data for similar instruments.


yr ns
op r i

64. Calibration interval must not exceed 365 days for instrument classified as GMP critical.
f c Fo

65. A calibration interval may be lengthened if the instrument or loop remains within tolerance,
to

without adjustment, for 3 successive calibrations.


en

66. A calibration interval may be shortened as a corrective action or part of one if the instrument
ns
Co

or loop is outside tolerance for two successive calibrations.


67. The new interval should be half the previous interval and cannot be less than 1 day, except
where instruments are designated as ‘Calibrate Before Use’.
Note: corrective actions to instrument failure are treated on an individual basis based on the
instruments’ criticality, use within the process, and closeness to the product, current tolerance
and previous calibration history.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 13 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

6.0 SAFETY PRECAUTIONS


Ensure you read the relevant Risk Assessments

7.0 CREATING/MODIFYING
INSRUMENT/PM/CALIBRATION INSTRUCTION
RECORD
Person Step Action
Responsible
Project/request 1. Tag the instrument appropriately to prevent its use until equipment
originator maintenance and validation/qualification determinations can be
completed. Note this step is only applicable for Instrument entry

.
se
type changes ru
he
ot
ny
fo y.

2. Complete the Entry/Change form and issue to the Engineering


d nl
ra
re o
ui es
eq os

dept.
r r rp
ne pu

Engineering 3. Review information and issue to relevant approvers.


ow ion
ht ct
ig pe

Relevant 4. Review and, if acceptable, approve request and return to CMMS


yr ns
op r i
f c Fo

Approver administrator.
to

CMMS 5. Enter relevant data from Record Entry/Change form into CMMS
en
ns
Co

Administrator and return paperwork to originator.


Project/request 6. Verify that equipment is appropriately tagged with correct
originator equipment code (only applicable for Instrument entry/changes) and
file paperwork in DCC.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 14 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

8.0 DEACTIVATING EQUIPMENT


Person Step Action
Responsible
Request 1. Identify the equipment to be de-activated and tag it ‘Deactivated’
Originator If Then
Scrapping Equipment • Raise a calibration work
order in order to calibrate the
instrument prior to removal.
• Dispose of it
appropriately and inform the
finance department.
Taking out of service • Raise a calibration work
temporarily order in order to calibrate the
instrument prior to removal.

.
se
ru

he
Prepare the equipment as
ot
ny
fo y.
d nl
ra

necessary, for inactive period.


re o
ui es
eq os

Calibration Co- 2. Deactivate the equipment and associated PM schedules in CMMS as


r r rp
ne pu
ow ion

ordinator appropriate.
ht ct
ig pe
yr ns

/Designee
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 15 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

9.0 ACTIVATING EQUIPMENT


Request 1. Raise a Calibration work order in order to calibrate the instrument prior to
Originator installation.
Calibration Co- 2. Activate the equipment and associated PM schedules in CMMS.
ordinator
/Designee

10.0 REQUEST PM EXTENSION


Person Step Action
Responsible
Requestor 1. Contact engineering with request for extension

.
se
Engineering 2. ru
Make determination on validity of request and amend target date as
he
ot
ny
fo y.

appropriate.
d nl
ra
re o
ui es

3. Record justification in comments section of work order and where


eq os
r r rp
ne pu

appropriate seek approval by QA.


ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 16 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

11.0 PERFORMING CALIBRATIONS


Person Step Action
Responsible
Calibration Co- 1. Release a work-order for the scheduled calibration.
ordinator / 2. Distribute the work-order to the colleague responsible for the calibration.
designee 3. Apply for an extension to the work order, if the calibration cannot be
completed by the due date.
If Then
Extension is granted The calibration must be completed by
the revised due date & the calibration
label must be replaced.

Extension is rejected Tag equipment ‘DO NOT USE’ on the

.
calibration due date and until calibration
se
ru
he
is completed.
ot
ny
fo y.
d nl
ra

Technician 4. Follow the calibration instruction attached to or referenced by the work-


re o
ui es
eq os

order.
r r rp
ne pu
ow ion

5. Complete the calibration record and ensure that each person involved in
ht ct
ig pe
yr ns

the work signs the form. Attach a calibration label showing the instrument
op r i
f c Fo

ID number, calibration date, next due date and initials.


to
en

6. Notify an area rep which instrument was worked on and where possible
ns
Co

request an equipment dry run prior to returning equipment to normal


operation. (only applicable when calibrating a critical parameter)

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 17 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Person Step Action


Responsible
Technician 7. Enter the calibration data into CMMS.
If Then
As-found data is ƒ Complete a QAR form in
un-acceptable and the accordance with SOP DEV-1002
instrument is GMP critical ‘Event and Deviation System’.

ƒ When entering data into the


CMMS, enter the QAR number in
the work order ‘Comments field’.

.
se
ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 18 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Technician As-left data is un- ƒ Tag equipment ‘DO NOT USE’


acceptable and seek a replacement.
ƒ If replacement is “like for like”
follow the procedure,’
Creating/Modifying Instrument records
in the Calibration Program’ outlined in
this SOP. Record the calibration results
for the replacement instrument in the
left results section of the certificate.
Enter the serial number of the original
and replacement instrument on the
work order. Clearly identify that the
replacement was carried out in the
comments section of the work order.
ƒ
.
se
If the replacement is not a “like for
ru
he
like” change, complete a change
ot
ny
fo y.
d nl
ra

request form (CRF) and enter the CRF


re o
ui es
eq os
r r rp

number in the comments section on the


ne pu
ow ion

work order. Request the calibration co-


ht ct
ig pe
yr ns

ordinator / designee to remove the


op r i
f c Fo

existing instrument, and setup the


to
en

replacement as per Creating/Modifying


ns
Co

instrument records in the calibration


program
8. Record calibration work in appropriate Equipment logbook.
9. Forward the completed Calibration Record to the Calibration Co-
ordinator/ Designee for approval.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 19 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Calibration Co- 10. Review the Calibration record and ensure the calibration was carried out
ordinator / in accordance with the task associated with the instrument. Confirm that
Designee the data on the record is accurate and corresponds to the data entered into
the CMMS.
11. Approve the calibration work order.
12. Forward the completed calibration records to the QA Document Control
Centre (DCC). Scheduled calibrations are filed by Instrument ID number.
13. Monitor the completion of calibrations throughout the scheduled period to
notify relevant colleagues if calibrations are overdue.

14. Facilitate the execution of calibrations throughout the facility.

15. Generate the following report.

.
se
ru
he
ot


ny
fo y.

A weekly ‘Calibration due report’ to review all overdue


d nl
ra
re o
ui es

and due calibrations for the coming month.


eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 20 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Pfizer Ireland Pharmaceuticals

PIP Maintenance Strategy


.
se
ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu

Revision 1
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 21 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Table of Contents

Section Description Page

1.0 Vision 3
2.0 Purpose 3
3.0 Scope 4
4.0 Regulatory Compliance & Environmental, Health and 4
Safety
5.0 Organisation and Administration 5
6.0 Responsibilities 5
7.0 Partnerships 6

.
se
ru
8.0 Asset Management 7
he
ot
ny
fo y.
d nl
ra

9.0 Work Control Systems 7


re o
ui es
eq os
r r rp

10.0 Work Planning and Scheduling 8


ne pu
ow ion
ht ct

11.0 Reliability Plans 9


ig pe
yr ns
op r i
f c Fo

12.0 Predictive and Preventive Maintenance 9


to

13.0 Maintenance Metrics 10


en
ns
Co

14.0 Materials Management 11


15.0 Cost Management 11
16.0 Maintenance Interface 12
17.0 Maintenance Evaluation and Continuous Improvement 12
18.0 Training and Development 12
19.0 Maintenance Teams and Knowledge Sharing 13
20.0 Communication 13
21.0 Abbreviations 14
22.0 Approvals 15

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 22 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

1.0 Vision
The Global Maintenance Initiative is outline as follows:

“Program to implement Reliability Based Maintenance practices consisting of assessments, master


planning, training, tool implementation, and continuous improvement.”

The PIP Maintenance Team will ensure alignment with the global GMI vision by means of the following:

™ Develop processes to enable Continuous Improvement of all aspects of Maintenance as a


Business; through the use of both RFT and GMI tools.
™ Utilise a data driven approach to enhance the quality and compliance of maintenance operations.
™ Ensure safety of colleagues and facilities through effective and compliant operation of
maintenance activities.
™ Promote leadership in maintenance departments and increase job satisfaction
™ Engage with other functions across product Value Streams to ensure Maintenance continues to
deliver value and ensure strong customer service.
™ Maintenance functions will deliver cost savings to the overall business in PIP.

.
se
ru
he
2.0 Purpose
ot
ny
fo y.
d nl
ra
re o
ui es
eq os

This strategy document outlines the elements for performing maintenance at all Pfizer Ireland
r r rp
ne pu

Pharmaceutical Facilities.
ow ion
ht ct
ig pe

This document is intended to put the processes in place to allow Pfizer Ireland Pharmaceuticals to strive
yr ns
op r i

towards maintenance excellence for the purpose of supporting operational excellence through equipment
f c Fo

reliability, compliance and safety whilst utilising resources in an effective and efficient manner.
to
en
ns

The expected outcomes of this strategy include:


Co

™ Optimised asset life cycle costing and overall equipment effectiveness. (OEE)
™ Reliability plans based on reliability practices and techniques.
™ Reduced risk in areas including regulatory compliance, environmental, health and safety.
™ Improved organisational effectiveness and engagement of maintenance colleagues.
™ Managing maintenance as a business based on metrics, monitoring and reporting.
™ Effective cost management
™ Effective partnering between maintenance and operations.
™ Increased sharing of knowledge and expertise across Pfizer Ireland Pharmaceuticals
™ Alignment with Right First Time (RFT)
™ Continuous improvement

3.0 Scope

This document applies to the following at all Pfizer Ireland Pharmaceuticals Facilities

™ Site Engineering/Maintenance Teams


™ Equipment Owners
™ Operations

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 23 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

™ Site Leadership Teams


™ Right First Time
™ Quality Operations
™ EHS

4.0 Regulatory Compliance & Environmental, Health and Safety


Maintenance activities performed by internal and external parties must be developed, planned and
executed in compliance with all regulatory guidelines, standards and policies.

Maintenance teams should promote a safe, compliant and clean working environment. Quality and
compliance should be addressed in the execution of all maintenance activities. Furthermore, contingency
plans must be in place to deal with unexpected adverse events.

These plans shall be developed in partnership with operations and communicated to all stakeholders.

.
se
ru
he
ot
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 24 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

5.0 Organisation and Administration

All maintenance roles should be clearly defined and documented.


Resource plans should be developed from metrics to determine staffing levels and shift allocations.

Insourcing/outsourcing decisions should be based upon customer requirements, core competencies,


associated risks, local market conditions and other relevant factors.

6.0 Responsibilities

Leadership:

™ Leadership should promote reliability based maintenance concepts to Operations and across site
partnerships
™ Engineering and maintenance leaders are responsible for communicating the maintenance
strategy to their maintenance teams, applying the strategy and setting maintenance performance
objectives.

.
se
ru
he
Site Maintenance Teams:
ot
ny
fo y.
d nl
ra
re o

The site maintenance teams shall be responsible for the following:


ui es
eq os
r r rp
ne pu

™ Ensure that planned equipment maintenance and calibrations are performed in a timely manner to
ow ion
ht ct

prevent unplanned failure of critical equipment and ensure compliance with regulatory
ig pe
yr ns

requirements.
op r i

™ Perform corrective actions to correct equipment failures, prevent potential equipment failures and
f c Fo

ensure equipment safety.


to

™ Perform root cause failure analysis on equipment failures.


en
ns

™ Continuous improvement in maintenance activities through equipment modification, PM


Co

optimisation, introduction of reliability techniques and implementation of RFT techniques.


™ Maintaining the CMMS system to ensure that equipment, instruments, maintenance schedules,
personnel and spare parts are correctly set up and maintained.
™ Development of asset care plans for new equipment.
™ Ensure that colleague training, development and performance management systems are in place
and effectively delivered.
™ Ensure that training plans are based on an overall training program that is developed in
conjunction with the needs of the business and maintenance colleagues.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 25 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Project Engineering:

Project Engineering shall be responsible for

™ Providing relevant details for set up of equipment on the CMMS system.


™ Engaging with maintenance colleagues for design and selection of new equipment.
™ Providing necessary handover documents for equipment.
™ Engaging in the development of asset care plans for new equipment.

Equipment Owners:

Equipment owners shall be responsible for

™ Notification to maintenance of equipment issues that may affect the reliability of that
equipment.
™ Engage in RCM, FMEA and RCFA activities in relation to the equipment.

Operations:

The operations team are responsible for

.
se
™ Operating equipment in a manner that supports reliability ru
he
ot

™ Monitoring equipment operation and highlighting potential issues that may impact on
ny
fo y.
d nl
ra

equipment performance
re o
ui es

™ Liaising with the maintenance planner and scheduler to ensure that the production schedule
eq os
r r rp

aligns with the maintenance schedule so that planned maintenance and calibrations can be
ne pu
ow ion

performed within their required target dates


ht ct

™ Engaging in RCM, FMEA & RCFA activities in relation to equipment


ig pe
yr ns
op r i
f c Fo
to
en

7.0 Partnerships
ns
Co

Equipment reliability and maintenance excellence is dependant on the partnerships between site
maintenance teams, equipments owners and equipment operators. Partnership agreements will ensure that
all stakeholders understand their role in the maintenance excellence process.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 26 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Partnership agreements shall contain the following:

Operations expectations of maintenance

™ Response times to emergency situations


™ Production Support requirements
™ Use of RCFA to eliminate recurring issues
™ Measures of reliability
™ Optimisation of planned maintenance activities to reduce impact of maintenance on equipment
availability
™ Prioritisation of work

Maintenance expectations of operations

™ Methods of reporting equipment issues


™ Agreements for equipment downtime to perform maintenance
™ Identification of potential equipment issues
™ Engagement in RCFA for recurring issues

.
se
8.0 Asset Management ru
he
ot
ny
fo y.
d nl
ra
re o

Assets shall be uniquely identified using an identification scheme structured into asset classes based on
ui es
eq os
r r rp

equipment characteristics.
ne pu
ow ion
ht ct

All maintenance activities performed on an asset whether performed internally or externally, planned or
ig pe
yr ns

unplanned shall be recorded in the CMMS to ensure a complete and accurate asset history.
op r i
f c Fo
to
en
ns

9.0 Work Control Systems


Co

A computerised maintenance management system (CMMS) shall be deployed to ensure proper work
control, regardless of who actually executes the work. The CMMS is essential for scheduling work and
resources, gathering equipment history reports for improvement purposes and managing maintenance
costs.

The work orders generated from the CMMS will contain sufficient information to enable a standardised
workflow that moves through eight phases: Request, Confirm, Plan, Schedule, Execute, Completion,
Review and Close out.

Approvals at the appropriate stages in the process shall ensure the quality and cost effectiveness of the
process.

Work Order Types:


Work order types are categorised as follows

Planned preventive work: This is work that is placed on a work schedule based on timed intervals or
equipment usage. This work is performed so that potential issues can be addressed prior to those issues
causing an unplanned equipment failure.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 27 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

Planned corrective work: This is corrective work that has been identified that could cause a potential
unplanned equipment failure but the potential failure is not imminent and this corrective work can be
placed on the work backlog and planned and scheduled.

Emergency Work: This is work that is required to be performed immediately to prevent failure or
restore operation of critical equipment.

Production Support Work: This is non repair work that is required to support the production operation
such as line set up, equipment operation assistance, scheduling assistance, etc.

Calibration: Periodic instrument calibrations.

Administration: Non repair work such as data retrieval, training, meeting attendance, etc.

CBM / Predictive: Work carried out utilising technologies that will monitor equipment performance and
identify potential failures based on results.

10.0 Work Planning and Scheduling

.
se
Maintenance work planning and scheduling is essential for maintenance excellence and brings benefits in
ru
he
terms of efficiencies through having work available for maintenance resources.
ot
ny
fo y.
d nl
ra
re o

The role of the maintenance planner and scheduler is to develop job plans for planned work to include
ui es
eq os

task lists, spare parts requirements, special tools required, work prioritisation and resource requirements.
r r rp
ne pu
ow ion

The planner and scheduler shall also be responsible for liaising with maintenance supervisors and
ht ct
ig pe

operations to ensure that equipment and resources are made available for routine maintenance to be
yr ns
op r i

performed, ensuring that equipment is reliable and regulatory and statutory are met.
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 28 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

11.0 Reliability Plans

Reliability plans shall be developed in accordance with the Pfizer Ireland Pharmaceutical reliability
strategy (*TO BE DEVELOPED)

The reliability plans shall incorporate reliability based maintenance principles, namely:

™ Asset identification
™ Criticality assessment
™ Asset performance standards and requirements
™ Determination of failure modes and effects
™ Periodic evaluation and continuous improvement.

Reliability plans are the specific tasks performed on an asset. These plans shall address all elements of
asset utilisation and performance including quality, safety, environmental protection, uptime
requirements and throughput.

Criticality assessment tools shall be utilised for assets, this provides the basis for the reliability plan of an
asset.

.
se
ru
he
Periodic reviews of criticality assessments and reliability plans shall be performed and any modification
ot

or usage change of an asset shall also trigger a review of the criticality assessment and reliability plan.
ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu
ow ion

12.0 Predictive (PdM) and Preventive (PM) Maintenance


ht ct
ig pe
yr ns
op r i
f c Fo

Proactive maintenance activity shall be promoted by maintenance teams. Inspections based on actual
measurements and data are preferred because they are typically more effective than those based on a
to
en

technician’s senses.
ns
Co

Predictive maintenance techniques are most effective and shall be utilised where possible. These
techniques are intended to identify the onset of a specific failure mode objectively through the
monitoring, measuring and trending of changes in equipment condition.

Vibration analysis, ultrasonic’s, thermography and electrical circuit evaluation are among the most
common PdM tools that can be applied by maintenance teams.

In addition, preventive maintenance practices such as inspection, adjustment, cleaning and lubrication
shall be utilised in the reliability plan.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 29 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

13.0 Maintenance Metrics


Metrics will allow the maintenance team and partners to evaluate performance and target areas of
opportunity for continuous improvement in equipment reliability and maintenance processes.
Maintenance metrics are essential in the approach of managing maintenance as a business in order to
provide the best value to our partners and customers.

Maintenance Metrics can be divided into three categories:

1: PGE Core Metrics – These are metrics that have been pre-defined by the Global Maintenance Team as
base metrics for a maintenance organization. The purpose of these metrics is to assist in strategical
decision making at a global, PIP and local level. These metrics are reported monthly to ILT, PGE,
Engineering Team Leaders and Maintenance Team Leaders. These metrics are also generally shared with
maintenance organisations elsewhere in the globe for knowledge sharing purposes. (*METRICS TO BE
DEFINED)

2: PIP Additional Metrics – These metrics are defined by the PIP maintenance team leaders as metrics
that would provide benefit for the operating environment of the PIP Sites. The purpose of these metrics is
to assist in strategic decision making at a PIP and local level. These metrics are reported monthly to ILT,
PGE, Engineering Team Leaders and Maintenance Team Leaders. (*METRICS TO BE AGREED BY

.
se
MTL’s) ru
he
ot
ny
fo y.

3: Site Specific Metrics – These are metrics that may be defined at a site level and are relevant to the site
d nl
ra
re o

maintenance teams specific needs. These metrics are recorded at the discretion of the site and are utilised
ui es
eq os

to assist in tactical decision making in relation to equipment reliability and maintenance processes.
r r rp
ne pu
ow ion

Site specific metrics may include but should not be limited to the following:
ht ct
ig pe
yr ns
op r i

™
f c Fo

OEE Measurement
™ Maintenance Cost Reports (By site, department and asset)
to

™ Past Due Work


en
ns

™ Backlog Measurement
Co

™ Percent Production Support


™ Stock outs of critical spares
™ Environmental releases attributable to maintenance

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 30 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

14.0 Materials Management

An effective materials management program is necessary to ensure the availability and delivery of parts,
tools, equipment and materials for the execution of the reliability plans.
This program balances inventory levels and the cost of inventory. It also ensures suppliers are managed
to provide Pfizer Ireland Pharmaceuticals with the best possible supply agreements.

Where possible, the Ireland sites should regionalise stockrooms and/or leverage availability of parts and
suppliers.

The materials management program shall address items including:

™ Material identification and storage


™ Inventory management
™ Controls
™ Replenishment systems
™ Stock codes linked to assets

.
se
ru
he
ot

15.0 Cost Management


ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp

Budgets shall be developed based upon predetermined maintenance activities including preventive
ne pu

maintenance, historical levels of unplanned maintenance, customer support requirements, materials, tools
ow ion
ht ct

and equipment needs etc.


ig pe
yr ns
op r i
f c Fo

The EMU cost template shall be used as a tool to capture and trend costs. Cost tracking and reporting
shall be performed on a monthly basis and compared against targets and benchmarks.
to
en
ns

Cost data collected as the asset level is preferred as it can be used to aid decisions to repair, refurbish or
Co

replace the asset.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 31 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

16.0 Maintenance Interfaces

Maintenance organisations are partners in the operations that they support, it is expected that
maintenance teams will have regular communications and meetings with their partners.

Reliability plans shall be reviewed with the asset owners to establish appropriate service levels and user
requirements.

17.0 Maintenance Evaluation and Continuous Improvement

Continuous improvement is enabled by measuring performance, setting improvement goals, tracking and
reporting progress towards those goals.

Pfizer Ireland Pharmaceutical maintenance teams will measure, track and report key performance metrics
as recommended by the Global Maintenance Team.

Metrics must be made visible to operations and be well understood by all maintenance colleagues.

.
se
ru
Regular assessments of maintenance operations shall be conducted to identify progress against each sites
he
ot

maintenance master plans, good practices and external benchmarks.


ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu

18.0 Training & Development


ow ion
ht ct
ig pe
yr ns
op r i

All maintenance colleagues will be competent and qualified to perform their duties through a
f c Fo

combination of their education, training and experience. There will be documented evidence available
to

for each individuals training status. Required training for the job will be identified through a job function
en

curricula which will be available for each job position. Colleagues will be responsible for ensuring they
ns
Co

are adequately trained prior to undertaking any task.

Every colleague will be encouraged to identify developmental opportunities to enhance their skills and
qualifications; this will be done with the support of maintenance leadership.

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 32 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

19.0 Maintenance Teams and Knowledge Sharing


To leverage the depth and breath of maintenance knowledge at Pfizer Ireland Pharmaceuticals,
maintenance teams shall be established and will regularly meet to share experiences and knowledge.

Leveraging items such as criticality assessments, toolkit applications such as PM optimisation, planning
and scheduling, supply and service agreements etc, is essential to strive towards a maintenance
excellence organisation.

The PIP maintenance leader’s team shall work together on tactical implementation of their goals and
objectives and stay closely linked to the Global Maintenance Team.

Individual maintenance team leaders are expected to support the Ireland Maintenance Team by:

™ Participating in meetings
™ Staying abreast of activities
™ Providing input in the form of good practices, learning’s etc
™ Utilising communications vehicles such as E-room/Sharepoint.

.
se
ru
20.0 Communications
he
ot
ny
fo y.
d nl
ra
re o
ui es

Communications vehicles shall be used to keep all stakeholders informed and to seek feedback on all
eq os
r r rp

maintenance activities at each Ireland site. Communications processes between maintenance teams will
ne pu
ow ion

be essential to promote knowledge sharing, good practices and successes. Communications at site,
ht ct

regional, area and global levels should be utilised.


ig pe
yr ns
op r i
f c Fo
to
en
ns
Co

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 33 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

21.0 Abbreviations

CBM CONDITIONED BASED MONITORING

CMMS COMPUTERISED MAINTENANCE


MANAGEMENT SYSTEM
EMU ENGINEERING MAINTENANCE AND
UTILITIES
EHS ENVIRONMENTAL, HEALTH AND SAFETY

FMEA FAILURE MODE AND EFFECTS ANALYSIS

.
se
OEE OVERALL EQUIPMENT EFFECTIVENESS ru
he
ot
ny
fo y.
d nl
ra

PdM PREDICTIVE MAINTENANCE


re o
ui es
eq os
r r rp
ne pu

PIP PFIZER IRELAND PHARMACEUTICALS


ow ion
ht ct
ig pe
yr ns
op r i

PM PLANNED MAINTENANCE
f c Fo
to

RCFA ROOT CAUSE FAILURE ANALYSIS


en
ns
Co

RCM RELIABILITY CENTRED MAINTENANCE

RFT RIGHT FIRST TIME

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 34 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19


Pfizer Biotechnology Ireland Pfizer Monoclonal Antibodies Small Scale Facility
IPPC Licence Application

22.0 Approvals

Author/Date: Approved By/Date:

_________________________________ _________________________________
Eugene O’ Callaghan, GMI Facilitator Michael Cohalan, MTL Ringaskiddy

Approved By/Date: Approved By/Date:

.
se
_________________________________ ru
_________________________________
he
ot

Michael Cleere, ETL LIAPI Ryan Cleary, ESM Dublin


ny
fo y.
d nl
ra
re o
ui es
eq os
r r rp
ne pu

Approved By/Date: Approved By/Date:


ow ion
ht ct
ig pe
yr ns
op r i
f c Fo
to
en

_________________________________ _________________________________
ns
Co

Tom Dineen, FCO LODP Jim Conway, MTL LOAPI

Approved By/Date: Approved By/Date:

_________________________________ _________________________________
Michael Boyle, ETL Sponsor Jim Brinkman, PGE Sponsor

J:\C2000-C2099\C2054\3) DOCUMENTS\40\REPORTS\IPPC LICENCE Attachment F.1 Arup Consulting Engineers


APPLICATION\IPPC ISSUE\PFIZER BIOTECHNOLOGY IPPC ATTACHMENT Page 35 24 September 2008
F.1.DOC

EPA Export 26-07-2013:01:46:19

You might also like